1
|
Wijaya V, Janďourek O, Křoustková J, Hradiská-Breiterová K, Korábečný J, Sobolová K, Kohelová E, Hošťálková A, Konečná K, Šafratová M, Vrabec R, Kuneš J, Opletal L, Chlebek J, Cahlíková L. Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents. Biomolecules 2022; 12:biom12060844. [PMID: 35740968 PMCID: PMC9221290 DOI: 10.3390/biom12060844] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 06/13/2022] [Accepted: 06/15/2022] [Indexed: 12/04/2022] Open
Abstract
Tuberculosis (TB) is a widespread infectious disease caused by Mycobacterium tuberculosis. The increasing incidence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains has created a need for new antiTB agents with new chemical scaffolds to combat the disease. Thus, the key question is: how to search for new antiTB and where to look for them? One of the possibilities is to search among natural products (NPs). In order to search for new antiTB drugs, the detailed phytochemical study of the whole Dicranostigma franchetianum plant was performed isolating wide spectrum of isoquinoline alkaloids (IAs). The chemical structures of the isolated alkaloids were determined by a combination of MS, HRMS, 1D, and 2D NMR techniques, and by comparison with literature data. Alkaloids were screened against Mycobacterium tuberculosis H37Ra and four other mycobacterial strains (M. aurum, M. avium, M. kansasii, and M. smegmatis). Alkaloids 3 and 5 showed moderate antimycobacterial activity against all tested strains (MICs 15.625–31.25 µg/mL). Furthermore, ten semisynthetic berberine (16a–16k) derivatives were developed and tested for antimycobacterial activity. In general, the derivatization of berberine was connected with a significant increase in antimycobacterial activity against all tested strains (MICs 0.39–7.81 μg/mL). Two derivatives (16e, 16k) were identified as compounds with micromolar MICs against M. tuberculosis H37Ra (MIC 2.96 and 2.78 µM). All compounds were also evaluated for their in vitro hepatotoxicity on a hepatocellular carcinoma cell line (HepG2), exerting lower cytotoxicity profile than their MIC values, thereby potentially reaching an effective concentration without revealing toxic side effects.
Collapse
Affiliation(s)
- Viriyanata Wijaya
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Ondřej Janďourek
- Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (O.J.); (K.K.)
| | - Jana Křoustková
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Kateřina Hradiská-Breiterová
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Jan Korábečný
- Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; (J.K.); (K.S.)
| | - Kateřina Sobolová
- Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; (J.K.); (K.S.)
| | - Eliška Kohelová
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Anna Hošťálková
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Klára Konečná
- Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (O.J.); (K.K.)
| | - Marcela Šafratová
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Rudolf Vrabec
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Jiří Kuneš
- Department of Bioorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic;
| | - Lubomír Opletal
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Jakub Chlebek
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
| | - Lucie Cahlíková
- ADINACO Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; (V.W.); (J.K.); (K.H.-B.); (E.K.); (A.H.); (M.Š.); (R.V.); (L.O.); (J.C.)
- Correspondence:
| |
Collapse
|
2
|
Wijaya V, Supriyatna S, Milanda T. Uji Aktivitas Antibakteri dari Isolat Daun Tendani (Goniothalamus Macrophyllus Hook. f. & Thomson.). J Trop Pharm Chem 2016. [DOI: 10.25026/jtpc.v3i4.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Tumbuhan tendani (Goniothalamus macrophyllus) secara empiris digunakan sebagai obat luar untuk infeksi kulit pada suku Dayak Punan. Penelitian ini bertujuan untuk mengetahui aktivitas senyawa aktif antibakteri yang terkandung dalam isolat dari fraksi etil asetat Daun G. macrophyllus. Fraksi etil asetat adalah fraksi teraktif yang diperoleh dari hasil pengujian aktivitas antibakteri. Isolat diperoleh dari proses pemisahan dan pemurnian menggunakan kromatografi kolom dan kromatografi lapis tipis preparatif. Isolat diuji dengan menggunakan metode difusi agar. Hasil uji aktivitas antibakteri isolat dengan konsentrasi 1,2 mg/50 μL (2,4 %) terhadap S. aureus ATCC 25923 menghasilkan diameter zona hambat sebesar 7,85 mm.
Kata kunci : Goniothalamus macrophyllus, aktivitas antibakteri, Staphylococcus aureus, isolat, senyawa aktif
Collapse
|